Encino, California Clinical Trials

A listing of Encino, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 64 clinical trials
Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI

This trial looks to study the safety and feasibility of using oxygen-enhanced molecular MRI to understand how cancer cells use oxygen differently than normal cells. Cancer cells tend to utilize (or not utilize) oxygen differently than normal cells. By using the oxygen-enhanced molecular MRI, researchers will be able to create …

brain metastasis
MET
brain tumor
cancer
MRI
UCLA / Jonsson Comprehensive Cancer Center
 (7.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

The purpose of this study to evaluate the efficacy of SAGE-217 in the treatment of participants with MDD.

major depressive disorder
antidepressants
depression
psychiatric disorder
scid
Sage Investigational Site
 (3.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +35 other locations
High-Risk Veteran Initiative

Veterans at high-risk for hospitalization, including those with complex care needs, represent a large population of VHA patients who often do not receive evidence-based primary care practices that would help them avoid the hospital and improve their health. The high-RIsk VETerans (RIVET) Program will implement evidence-based practices that can support …

VA Greater Los Angeles Healthcare System, Sepulveda, CA
 (6.4 away) Contact site
  • 0 views
  • 21 Sep, 2021
  • +2 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
tirzepatide
body mass index
dulaglutide
Valley Clinical Trials, Inc.
 (6.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

electrocardiogram (ecg)
critically ill
electrocardiogram
dexamethasone
intrauterine device (iud)
Coronavirus Research Institute- Testing Site
 (7.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

fitusiran
bethesda assay
factor ix
severe haemophilia a
haemophilia a
Investigational Site Number 8400002
 (7.8 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +10 other locations
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475).

Call for Information (Investigational Site 0017)
 (10.0 away) Contact site
  • 0 views
  • 20 Jul, 2022
  • +23 other locations
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Cedars-Sinai Medical Center
 (10.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Clinical Testing of Beverly Hills
 (1.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

allogeneic transplantation
investigational treatment
cancer
hematologic malignancy
UCLA
 (7.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations